[{"@context":"https:\/\/schema.org\/","@type":"Article","@id":"https:\/\/www.evergreenhs.org\/evergreen-health-and-ub-department-of-medicine-participating-in-clinical-trial-investigating-long-acting-injectable-treatment-for-hiv\/#Article","mainEntityOfPage":"https:\/\/www.evergreenhs.org\/evergreen-health-and-ub-department-of-medicine-participating-in-clinical-trial-investigating-long-acting-injectable-treatment-for-hiv\/","headline":"Evergreen Health and UB Department of Medicine Participating in Clinical Trial investigating long-acting injectable treatment for HIV","name":"Evergreen Health and UB Department of Medicine Participating in Clinical Trial investigating long-acting injectable treatment for HIV","description":"BUFFALO, NY &ndash; May 16, 2018 &ndash; Evergreen Health and the University at Buffalo Department of Medicine &ndash; HIV and Infectious Diseases are participating in a multicenter clinical trial investigating the safety and efficacy of a regimen to treat HIV that is administered in monthly injections. ViiV Healthcare, the global specialist HIV company, majority owned&hellip;","datePublished":"2019-01-07","dateModified":"2019-01-07","author":{"@type":"Person","@id":"https:\/\/www.evergreenhs.org\/author\/jperks\/#Person","name":"James Perks","url":"https:\/\/www.evergreenhs.org\/author\/jperks\/","identifier":17,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/4447077c1ab09d6dff6c9577c4633b2844ccb6eb97bfbc1eaaf492afa7965cd3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4447077c1ab09d6dff6c9577c4633b2844ccb6eb97bfbc1eaaf492afa7965cd3?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Evergreenhs","logo":{"@type":"ImageObject","@id":"https:\/\/www.evergreenhs.org\/wp-content\/uploads\/2019\/07\/Evergreen-Health-Signature-Logo.jpg","url":"https:\/\/www.evergreenhs.org\/wp-content\/uploads\/2019\/07\/Evergreen-Health-Signature-Logo.jpg","width":250,"height":108}},"image":{"@type":"ImageObject","@id":"https:\/\/www.evergreenhs.org\/wp-content\/uploads\/2020\/10\/photo.png","url":"https:\/\/www.evergreenhs.org\/wp-content\/uploads\/2020\/10\/photo.png","width":36,"height":36},"url":"https:\/\/www.evergreenhs.org\/evergreen-health-and-ub-department-of-medicine-participating-in-clinical-trial-investigating-long-acting-injectable-treatment-for-hiv\/"},{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","@id":"https:\/\/www.evergreenhs.org\/evergreen-health-and-ub-department-of-medicine-participating-in-clinical-trial-investigating-long-acting-injectable-treatment-for-hiv\/#BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Evergreen Health and UB Department of Medicine Participating in Clinical Trial investigating long-acting injectable treatment for HIV","item":"https:\/\/www.evergreenhs.org\/evergreen-health-and-ub-department-of-medicine-participating-in-clinical-trial-investigating-long-acting-injectable-treatment-for-hiv\/#breadcrumbitem"}]}]